Australia markets closed

Eterna Therapeutics Inc. (ERNA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.9650+0.0650 (+3.42%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
115
68
0
0
0
Cost of revenue
247
236
0
-
-
Gross profit
-132
-168
0
-
-
Operating expenses
Research development
5,704
5,920
10,392
12,705
3,951
Selling general and administrative
15,309
14,586
16,555
14,724
3,297
Total operating expenses
21,013
20,506
26,947
27,429
7,248
Operating income or loss
-21,145
-20,674
-26,947
-27,429
-7,248
Interest expense
-
614
30
74
43
Total other income/expenses net
-495
-521
2,443
-94,978
-19,240
Income before tax
-22,903
-21,671
-24,534
-122,481
-7,291
Income tax expense
-4
-3
45
64
0
Income from continuing operations
-22,899
-21,668
-24,579
-122,545
-7,291
Net income
-22,899
-21,668
-24,579
-122,545
-7,291
Net income available to common shareholders
-22,915
-21,684
-24,595
-122,561
-7,291
Basic EPS
-3.96
-4.08
-8.06
-56.61
-3.51
Diluted EPS
-3.96
-4.08
-8.06
-56.61
-3.51
Basic average shares
4,871
5,314
3,051
2,165
2,076
Diluted average shares
5,410
5,314
3,051
2,165
2,076